IRIS
TESSITORE, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.071
EU - Europa 3.097
AS - Asia 2.620
SA - Sud America 390
AF - Africa 40
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.971
SG - Singapore 1.111
RU - Federazione Russa 649
CN - Cina 586
IE - Irlanda 557
IT - Italia 439
BR - Brasile 343
DE - Germania 338
SE - Svezia 293
TR - Turchia 252
VN - Vietnam 245
HK - Hong Kong 228
FR - Francia 194
GB - Regno Unito 184
UA - Ucraina 145
FI - Finlandia 133
CA - Canada 57
BD - Bangladesh 47
IN - India 45
CZ - Repubblica Ceca 40
MX - Messico 30
BE - Belgio 23
ES - Italia 22
JP - Giappone 22
PL - Polonia 22
NL - Olanda 20
ZA - Sudafrica 20
IQ - Iraq 18
AR - Argentina 14
EC - Ecuador 9
AT - Austria 8
KR - Corea 8
ID - Indonesia 7
VE - Venezuela 7
MY - Malesia 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CO - Colombia 5
PK - Pakistan 5
SA - Arabia Saudita 5
CH - Svizzera 4
LT - Lituania 4
PH - Filippine 4
PT - Portogallo 4
TN - Tunisia 4
UZ - Uzbekistan 4
CL - Cile 3
DZ - Algeria 3
EU - Europa 3
JM - Giamaica 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
UY - Uruguay 3
BG - Bulgaria 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
LY - Libia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CD - Congo 1
CM - Camerun 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
GY - Guiana 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 11.227
Salva come PNG Salva come JPEG
Città #
Chandler 622
Singapore 596
Dallas 584
Jacksonville 566
Dublin 553
San Jose 491
Ashburn 291
Boardman 227
Hong Kong 225
Santa Clara 223
Council Bluffs 159
Izmir 135
New York 123
The Dalles 104
Moscow 101
Beijing 98
Nanjing 98
Munich 85
Princeton 80
San Mateo 80
Lawrence 79
Ho Chi Minh City 74
Wilmington 74
Ann Arbor 73
Los Angeles 70
L'aquila 55
Lauterbourg 55
L’Aquila 54
Hanoi 46
Bremen 45
Woodbridge 43
Helsinki 41
Brno 39
Milan 37
Rome 36
São Paulo 36
Nanchang 35
Shenyang 29
Dong Ket 28
Seattle 28
Montreal 24
Brussels 23
Shanghai 23
Tianjin 22
Verona 22
Warsaw 22
Tokyo 21
Aquila 20
Kitzingen 20
Columbus 19
Turku 19
Brooklyn 18
Houston 18
Orem 18
Atlanta 17
Frankfurt am Main 17
Des Moines 16
Johannesburg 16
London 16
Jiaxing 15
Mountain View 15
Casoria 14
Hebei 14
Hefei 14
Philadelphia 14
Phoenix 14
Chennai 13
Kunming 13
Lappeenranta 13
Manchester 13
Zhengzhou 13
Changsha 12
Da Nang 12
Falkenstein 12
Mexico City 11
Norwalk 11
Poplar 11
San Francisco 11
Amsterdam 10
Chicago 10
Pune 10
Toronto 10
Dearborn 9
Denver 9
Guangzhou 9
Ningbo 9
Assago 8
Haiphong 8
Jinan 8
Redwood City 8
Stockholm 8
Boston 7
Brasília 7
Campinas 7
Lissone 7
Ninh Bình 7
Nuremberg 7
Querétaro 7
Taizhou 7
Auburn Hills 6
Totale 7.212
Salva come PNG Salva come JPEG
Nome #
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 194
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 184
Involvement of an arachidonic-acid-dependent pathway in the interferon-beta-mediated expression of C202 gene in Ehrlich-ascites-tumor cells 181
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 179
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 176
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 172
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 171
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 168
Therapeutic Use of MicroRNAs in Cancer 167
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 166
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 164
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 162
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 157
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 155
Emerging role of isomirs in cancer: State of the art and recent advances 152
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 151
Longitudinal monitoring of mRNA levels of regulatory T cell biomarkers by using non-invasive strategies to predict outcome in renal transplantation 150
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 149
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 148
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 147
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 144
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 144
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 144
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 144
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy 144
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 143
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 140
Angiotensin II stimulates intercellular adhesion molecule-1(ICAM1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo 138
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 138
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 136
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 136
New mutations and protein variants of NBSI are identified in cancer cell lines 132
Ultrasound-based method for the identification of novel microrna biomarkers in prostate cancer 132
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 130
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 129
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 129
crosstalk between nf-kb and shh pathways in prostate cancer 127
the role of kctd11 tumor suppressor gene in prostate cancer 125
Novel P53 mutations detected by FAMA in colorectal cancers 123
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 123
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 123
Codon optimization by 0-1 linear programming 123
A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial 122
Characterization of a novel HLA-Cw*02 variant, Cw*0208, in a Caucasian individual 121
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 121
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 120
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 120
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 118
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 118
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 116
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 115
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer 115
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 112
MicroRNAs in the DNA Damage/Repair Network and Cancer 110
Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing 109
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 109
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 108
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 107
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 106
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery 106
Identification of the uncommon allele HLA-A*7403 in a Caucasian renal transplant cadaveric donor: Extension of the exon 4 sequence 106
A NEW ALLELE, MICA*078, IDENTIFIED IN A MOROCCAN INDIVIDUAL WITH CELIAC DISEASE 105
Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH 104
Ultrasound as a New Method for the Release and Identification of Novel microRNAs and Proteins as Candidate Biomarkers in Pancreatic Cancer 103
Identification of a novel HLA-DRB1*11 allele: DRB1*1152 103
Identification of the novel allele B*4427 and a confirmatory sequence (B*44022) 102
Pharmacogenetics and clinical oncology: a new deal for personalized therapies 101
Prognostic value of p53 molecular status in high-risk primary breast cancer 101
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 101
High sensitivity of detectionof TP53 somatic mutations by fluorescence-assisted mismatch analysis 101
MICA∗078: A novel allele identified in a moroccan individual affected by celiac disease. 100
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 100
Identification of a novel allele variant of HLA-B*57 in a Caucasian Moroccan individual: B*57032 99
MiRNome analysis in high-fat diet-induced hepatocarcinoma. 99
Smart hydrogel particles: Biomarker harvesting: One-step affinity purification, size exclusion, and protection against degradation 99
Identification of a novel HLA-A*02 allele, A*027401* 97
Prenatal diagnosis of a rhodopsin mutation using chemical cleavage of the mismatch 96
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers. 96
Serum low-molecular-weight protein fractionation for biomarker discovery 95
Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy 94
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 94
Increased CD1D polymorphism: identification of two novel alleles, CD1D*03 and *04, in individuals from Morocco. 93
Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122 92
Analytical scanning of p53 mutations by FAMA (fluorescence assisted mismatch analysis) in colorectal cancers and preliminary prognostic findings. 91
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 90
Role of bcr-abl in the regulation and inhibition of apoptosis 88
An initial characterization of the serum phosphoproteome. 87
Mass spectrometry driven discovery proteomics of serum from mice with human ovarian cancer resulted in identification of a potential cancer-origin biomarker that correlates with peritoneal tumor burden. 86
IDENTIFICATION OF TWO NOVEL ALLELES, CD1D*03 AND*04, IN INDIVIDUALS FROM MOROCCO 82
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 82
Efficacy and tolerability of Everolimus-Exemestane combination therapy in metastatic breast cancer patients: experience in Real Life 80
MicroRNAs expression analysis in high-fat diet induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 72
Detection of NBS1 (Nibrin) mutations in breast and ovarian cancer 60
null 38
null 35
Anthracycline-Free Neoadjuvant Pertuzumab-Trastuzumab-Taxane in Patients with HER2-Positive Early Breast Cancer: Hormone Receptor Status as a Key Determinant of Pathological Complete Response 5
Effect of Osteoblast-Derived Extracellular Vesicles on Osteosarcoma Cells’ Transcriptional Profile: Role of Shuttled miRNAs 4
Totale 11.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 0 0 0 0 0 0 60
2021/2022514 35 25 128 43 21 5 9 28 35 9 33 143
2022/20231.684 106 125 30 213 167 184 2 86 682 11 56 22
2023/2024474 46 26 19 41 31 118 2 45 0 18 29 99
2024/20251.993 83 62 228 103 193 158 278 188 366 68 137 129
2025/20264.158 218 387 442 544 417 305 571 108 325 569 204 68
Totale 11.474